Clinical Trials Browser

Interventional × Hepatitis C × Clear all

NCT03520660 2026-04-14

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT02772003 2026-04-13

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Phase 1 Active not recruiting

Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular

NCT01022476 2026-04-06

LIVERAL

Phase 1/2 Completed

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Phase 2 Completed

15 enrolled 8 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT07038863 2025-06-26

Mondelta

Phase NA Not yet recruiting

Gastrointestinal

Hepatitis D, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT03534141 2025-05-16

MHALT

Phase NA Terminated

175 enrolled 19 charts

GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

NCT04710641 2025-03-06

OUTREACH2

Phase 2 Completed

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

NCT02935478 2025-02-06

Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation

Phase NA Suspended

GastrointestinalOther

Body Weight, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Obesity, Weight Loss

NCT06745895 2024-12-20

MATCHES

Phase NA Recruiting

Gastrointestinal

Hepatitis C, Colorectal Neoplasms

NCT02143401 2024-11-22

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Gastrointestinal

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms

NCT04540081 2023-12-27

CLOVER

Phase NA Completed

20,000 enrolled

GastrointestinalOtherThoracic

Colonic Neoplasms, Hepatitis C, Herpes Zoster, Lung Neoplasms, Obesity, Pneumonia, Bacterial, Tobacco Use Cessation

NCT03903185 2023-08-22

Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy

Phase 1/2 Completed

Other hematologic neoplasm

Hepatitis C, Leukemia, Hematologic Neoplasms, Hepatitis C, Chronic

NCT04653818 2023-04-04

RCT

Phase 4 Completed

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Recurrence

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT02970136 2021-12-28

Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

Phase NA Completed

754 enrolled 9 charts

Gastrointestinal

Acquired Immunodeficiency Syndrome, Hepatitis C, Colorectal Neoplasms

NCT04037046 2021-04-30

Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening

Phase NA Completed

Hepatitis C

NCT03706742 2021-04-20

STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention

Phase NA Completed

12,386 enrolled

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT01821963 2020-09-24

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Phase 3 Terminated

1 enrolled 3 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Infections

NCT04546802 2020-09-14

HATCHeT

Phase 3 Withdrawn

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT04395118 2020-07-02

STOP-HCC

Phase NA Withdrawn

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT02868242 2020-03-02

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Phase 2 Completed

19 enrolled 14 charts

Hepatitis C, Liver Diseases, Virus Diseases, Hepatitis C, Chronic

NCT02717949 2019-01-08

Optimal

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

NCT02833298 2018-10-12

Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

Phase NA Completed

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT00513461 2018-08-10

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Phase 2 Completed

110 enrolled 21 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT03261349 2017-08-25

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Phase 2 Unknown

Hepatitis C, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT01804829 2017-03-15

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

Phase 3 Completed

Gastrointestinal

Hepatitis, Viral, Human, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis, Virus Diseases

NCT01790633 2016-12-13

OPTISCREEN-III

Phase NA Completed

327 enrolled 9 charts

Gastrointestinal

Acquired Immunodeficiency Syndrome, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

NCT01559844 2016-07-27

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Phase 2 Completed

61 enrolled 25 charts

Gastrointestinal

Bronchiolitis Obliterans Syndrome, Hepatitis, Hepatitis C, Carcinoma, Hepatocellular

NCT01350167 2011-05-24

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

Phase NA Unknown

Gastrointestinal

Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Liver Neoplasms, End Stage Liver Disease

NCT00822991 2010-12-30

Sonazoid Enhanced Liver Cancer Trial for Early Detection

Phase NA Unknown

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT00165633 2008-12-09

A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma

Phase 2/3 Terminated

Gastrointestinal

Carcinoma, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Recurrence

NCT00273247 2006-01-09

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

Phase 3 Completed

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis